These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15072832)

  • 1. CXCR3-binding chemokines in multiple myeloma.
    Pellegrino A; Antonaci F; Russo F; Merchionne F; Ribatti D; Vacca A; Dammacco F
    Cancer Lett; 2004 Apr; 207(2):221-7. PubMed ID: 15072832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
    Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
    Xanthou G; Duchesnes CE; Williams TJ; Pease JE
    Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
    Xanthou G; Williams TJ; Pease JE
    Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular characteristics of neuroblastoma cells: regulation by the ELR--CXC chemokine CXCL10 and expression of a CXCR3-like receptor.
    Goldberg-Bittman L; Sagi-Assif O; Meshel T; Nevo I; Levy-Nissenbaum O; Yron I; Witz IP; Ben-Baruch A
    Cytokine; 2005 Feb; 29(3):105-17. PubMed ID: 15613278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
    Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
    J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
    Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
    Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival.
    Giuliani N; Bonomini S; Romagnani P; Lazzaretti M; Morandi F; Colla S; Tagliaferri S; Lasagni L; Annunziato F; Crugnola M; Rizzoli V
    Haematologica; 2006 Nov; 91(11):1489-97. PubMed ID: 17082008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis.
    Segerer S; Banas B; Wörnle M; Schmid H; Cohen CD; Kretzler M; Mack M; Kiss E; Nelson PJ; Schlöndorff D; Gröne HJ
    Am J Pathol; 2004 Feb; 164(2):635-49. PubMed ID: 14742268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia.
    Katoh S; Fukushima K; Matsumoto N; Ehara N; Matsumoto K; Yamauchi A; Hirashima M
    Int Arch Allergy Immunol; 2005 Jul; 137(3):229-35. PubMed ID: 15956791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
    Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
    Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
    De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
    Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.
    Furuya M; Suyama T; Usui H; Kasuya Y; Nishiyama M; Tanaka N; Ishiwata I; Nagai Y; Shozu M; Kimura S
    Hum Pathol; 2007 Nov; 38(11):1676-87. PubMed ID: 17707463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human osteoblasts express functional CXC chemokine receptors 3 and 5: activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and beta-N-acetylhexosaminidase release.
    Lisignoli G; Toneguzzi S; Piacentini A; Cattini L; Lenti A; Tschon M; Cristino S; Grassi F; Facchini A
    J Cell Physiol; 2003 Jan; 194(1):71-9. PubMed ID: 12447991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
    Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM
    Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function relationship between the human chemokine receptor CXCR3 and its ligands.
    Clark-Lewis I; Mattioli I; Gong JH; Loetscher P
    J Biol Chem; 2003 Jan; 278(1):289-95. PubMed ID: 12417585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma.
    Ria R; Vacca A; Ribatti D; Di Raimondo F; Merchionne F; Dammacco F
    Haematologica; 2002 Aug; 87(8):836-45. PubMed ID: 12161360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells.
    Pellegrino A; Ria R; Di Pietro G; Cirulli T; Surico G; Pennisi A; Morabito F; Ribatti D; Vacca A
    Br J Haematol; 2005 Apr; 129(2):248-56. PubMed ID: 15813853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.
    Romagnani P; Annunziato F; Lasagni L; Lazzeri E; Beltrame C; Francalanci M; Uguccioni M; Galli G; Cosmi L; Maurenzig L; Baggiolini M; Maggi E; Romagnani S; Serio M
    J Clin Invest; 2001 Jan; 107(1):53-63. PubMed ID: 11134180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.